摘要
目的探讨临床药师在新生儿人型支原体脑膜炎治疗中的作用。方法回顾性分析临床药师参与1例莫西沙星治疗新生儿人型支原体脑膜炎的病例,并系统回顾关于莫西沙星用于新生儿人型支原体脑膜炎的相关文献,分析其临床应用现状与安全性。结果临床药师结合相关文献,通过对莫西沙星用于新生儿人型支原体脑膜炎的风险和获益进行评估,参与抗感染方案的调整与治疗过程的药学监护,患儿最终好转出院。结论在充分评估风险获益后,莫西沙星可作为治疗危及生命或难治性新生儿人型支原体脑膜炎的有效选择。
Objective To investigate the role of clinical pharmacists in the treatment of neonatal Mycoplasma hominis meningitis.Methods Retrospective analysis was performed on a case of moxifloxacin treatment for neonatal Mycoplasma hominis meningitis,in which clinical pharmacists participated,and a systematic review of the literature was conducted to evaluate its clinical application and safety.Results Based on the relevant literature,clinical pharmacists assessed the risks and benefits of moxifloxacin for neonatal Mycoplasma hominis meningitis,participated in the adjustment of anti-infection regimens,and carried out pharmaceutical care during the treatment.The neonate ultimately achieved a stable clinical condition and was discharged.Conclusion Following a comprehensive risk-benefit assessment,moxifloxacin can be used as an effective treatment option for life-threatening or refractory neonatal Mycoplasma hominis meningitis.
作者
张竞佳
张永胜
欧阳珊
Zhang Jingjia;Zhang Yongsheng;Ou Yangshan(Department of Pharmacy,Shenzhen Longhua District Maternal and Child Healthcare Hospital,Shenzhen 518000,China;Department of Pharmacy,Guangzhou Women and Children's Medical Center,Guangzhou 510120,China)
出处
《实用药物与临床》
2025年第8期593-596,共4页
Practical Pharmacy and Clinical Remedies
基金
广东省药学会科学研究基金(2023KJ09)。
